FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Stakeholder Comments on Cell, Gene Guidance

[ Price : $8.95]

Three stakeholders recommend changes to an FDA draft guidance on human- and animal-derived materials in cell and gene therapeutic ...

FDA Publishes ICH Bioequivalence Guidance

[ Price : $8.95]

FDA publishes an International Council on Harmonization guidance on bioequivalence studies for immediate-release solid oral dosage...

FDA Clears Life Spine Sacroiliac Fixation Device

[ Price : $8.95]

FDA clears a Life Spine 510(k) for its ARx SAI (sacral alar iliac) Spinal Fixation System.

FDA May Allow Novel Carve-Ins: Attorneys

[ Price : $8.95]

Two Axinn attorneys say FDA may be signaling more flexibility in considering novel Section viii carve-in statements in ANDAs.

Man Indicted for Selling Counterfeit Cancer Drugs

[ Price : $8.95]

The Justice Department says a resident of India has been indicted on federal charges of trafficking in fake cancer drugs sold in t...

New Quantitative Medicine CoE Resources

[ Price : $8.95]

The CDER Quantitative Medicine Center of Excellence posts four new resources.

Biosimilar User Fee Rates For FY 2025

[ Price : $8.95]

Federal Register notice: FDA set biosimilar user fee rates for fiscal year 2025.

OTC Monograph FY 2025 User Fee Rates

[ Price : $8.95]

Federal Register notice: FDA posts the over-the-counter monograph order request fee rates for fiscal year 2025.

Info Collection on FDA Quantitative Testing

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Generic Clearance for Quantitative Tes...

CDER Used AI/ML in Kineret EUA

[ Price : $8.95]

CDER explains how it used artificial intelligence/machine learning (AI/ML) to help identify the patient population most likely to ...